Skip to main content
logo
Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden flag Sweden · Delayed Price · Currency is SEK
10.10
+0.17 (1.71%)
Sep 2, 2026, 5:29 PM CET

Xspray Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.472.47----
Revenue Growth
------
Gross Profit
2.472.47----
Operating Income
-147.17-159.13-283.24-180.77-131.38-96.95
Net Income
-159.44-171.44-285.52-179.67-131.67-96.7
Earnings Per Share
-3.82-4.46-8.62-6.76-6.25-5.03
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
179.91153.75208.24166.3120.17271.88
Total Debt
147.3148.39128.2236.812.133.23
Net Cash (Debt)
32.65.3580.02129.5118.04268.65
Net Cash Growth
--93.31%-38.21%9.70%-56.06%-16.23%
Net Cash Per Share
0.780.142.414.875.6013.96

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-150.35-193.16-222.37-203.28-110.18-51.61
Capital Expenditures
---4.38-2.69-24.47-1.31
Free Cash Flow
-150.35-193.16-226.75-205.97-134.65-52.92
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%----
Operating Margin
-5968.01%-6453.12%----
Pretax Margin
-6468.65%-6956.49%----
Profit Margin
-6465.49%-6952.27%----
FCF Margin
-6096.71%-7833.05%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.762.022.6214.5314.53
PS Ratio
190.94532.36----